RaySearch Laboratories AB (publ) (LON:0GRZ)

London flag London · Delayed Price · Currency is GBP · Price in SEK
335.50
+9.11 (2.79%)
At close: Jul 1, 2025
135.94%
Market Cap 911.45M
Revenue (ttm) 97.66M
Net Income (ttm) 17.24M
Shares Out n/a
EPS (ttm) 0.50
PE Ratio 52.86
Forward PE n/a
Dividend 0.23 (0.07%)
Ex-Dividend Date May 23, 2025
Volume 1,195
Average Volume 5,671
Open 337.75
Previous Close 326.39
Day's Range 335.00 - 342.00
52-Week Range 125.85 - 337.00
Beta 1.11
RSI 68.83
Earnings Date Aug 8, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation... [Read more]

Industry Prepackaged Software
Founded 2000
Employees 416
Stock Exchange London Stock Exchange
Ticker Symbol 0GRZ
Full Company Profile

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.